December 1, 2023
PCF names new directors
The Pharmacy Compounding Foundation has elected five board members
December 1, 2023
Our state-by-state 795-797-800 chart has been updated
APC has posted an updated version of our compilation of state by state adoption of USP <795>, <797>, and <800>.
December 1, 2023
Novo alleges potency discrepancy, impurities in compounded semaglutide
We’ll let you read it for yourself. Interesting how the reporter seems to take Novo’s word for it, no?
December 1, 2023
APC files amicus in Novo case against Tennessee compounder
A U.S. District Court judge approved APC filing an amicus brief this week in Novo Nordisk’s lawsuit against Tennessee compounder (and APC PFM) DCA Pharmacy.
December 1, 2023
A $100,000 deficit
One of the challenges of being an ambitious but resource-poor association is that we have to spend a lot of time asking members like you for money.
November 30, 2023
Telling your story, one reporter at a time
The photo inset below on the left was taken last Friday morning at Preston’s Pharmacy (a PFM, I might add) in Arlington, Virginia. It’s not a pharmacist or technician in the photo. It’s a healthcare reporter.
November 30, 2023
There’s a lot you can learn from errors
Patient safety is job one in any pharmacy, but especially in compounding pharmacies. So on those rare occasions when errors occur — in your pharmacy or someone else’s — you want to be able to learn from them.
November 30, 2023
What does FD&C Act really say about USP compliance?
In response to inquiries from state boards of pharmacy regarding the enforceability of revised USP Chapters <795>, <797>, and <800>, a recent memo aims to clarify references in the Food, Drug & Cosmetic Act.
November 30, 2023
Letter seeks clarity on semaglutide compounding in California
Last week, we sent a letter to the California Board of Pharmacy requesting clarification of its position on compounding semaglutide.
